As for adults, patients with anti-LGI1 encephalitis do show better long-term outcomes and lower recurrent rates than those with anti-NMDAR encephalitis (Malter et al., 2014; Finke et al., 2017). This evidence concerns the gene LGI1 and encephalitis.